Belgium vs Lesotho: Access to anti-retroviral drugs, male
Belgium
88.0%
in 2023
Lesotho
88.0%
in 2024
Belgium rank
23rd
Lesotho rank
23rd
Access to anti-retroviral drugs, male over time
- Belgium
- Lesotho
How they compare
Belgium currently reports 88.0% against 88.0% in Lesotho, a difference of 0.0%.
Across all 24 years both countries report, Belgium has been ahead every year.
Belgium ranks 23rd and Lesotho ranks 23rd of 141 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.5% | 7.3% | 43.2% | Belgium |
| 2010s | 83.6% | 47.6% | 36.0% | Belgium |
| 2020s | 87.8% | 80.8% | 7.0% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Belgium or Lesotho?
- Belgium, at 88.0% against 88.0% in Lesotho as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Belgium and Lesotho?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Lesotho?
- 24 years are reported by both, from 2000 to 2023.
- How do Belgium and Lesotho rank globally for access to anti-retroviral drugs, male?
- Belgium ranks 23rd and Lesotho ranks 23rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.